![(R)-2-HG - a-KG-dependent dioxygenases inhibitor. CAS# 103404-90-6 60225 3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/xbio_R_-2-HG.png?v=1742651846)
Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide
InChi: InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17
InChiKey: HLCDNLNLQNYZTK-UHFFFAOYSA-N
Right now MK-1775 is in phase I/II clinical trials for various cancers
NVP-BGT226
(R)-2-HG - a-KG-dependent dioxygenases inhibitor. CAS# 103404-90-6 60225 3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamideMutations, CAS No. 103404 90 6, in IDH1 and IDH2, the genes coding for isocitrate dehydrogenases 1 and 2, are common in several human cancers, such as leukemia and glioma, and result in overproduction of the (R) enantiomer of 2 hydroxyglutarate [(R) 2 HG]. Elucidation of the role of IDH mutations and (R) 2 HG in leukemogenesis has been hampered by a lack of appropriate cell based models. It has been recently reported that a canonical IDH1 mutant, IDH1